Medicinal category NFA-VPS
Dronspot 60 mg/15 mg spot-on solution for medium cats weighing 2.5kgs - 5kgs.
A topical spot on worming treatment for medium cats against roundworms and tapeworms.
For the treatment of mixed parasitic infections in cats caused by roundworms and tapeworms of the following species:
Toxocara cati (mature adult, immature adult, L4 and L3)
Toxocara cati (L3 larvae) - treatment of queens during late pregnancy to prevent lactogenic transmission to the offspring
Toxascaris leonina (mature adult, immature adult and L4)
Ancylostoma tubaeforme (mature adult, immature adult and L4)
Dipylidium caninum (mature adult and immature adult)
Taenia taeniaeformis (adult)
Echinococcus multilocularis (adult)
Can be used during pregnancy and lactation
For the treatment of queens to prevent transmission of Toxocara cati (L3 larvae) through the milk to the offspring, a single administration per treatment approximately seven days prior to expected birthing is effective
Emodepside is a substrate for P-glycoprotein. Co-treatment with other drugs that are P-glycoprotein substrates/inhibitors (for example, ivermectin and other antiparasitic macrocyclic lactones, erythromycin [antibiotic], prednisolone [steroids) and cyclosporine [immunosuppressant]) could give rise to pharmacokinetic drug interactions. The potential clinical consequences of such interactions have not been investigated. If your cat is receiving any medications, please contact your vet to discuss this before applying the product. Similarly, please inform your vet that you are using this product if s/he provides your cat with any medication.
Detailed information on this veterinary medicine is available in the data sheet here and instructions will be included with the product. If you have questions about the use of this veterinary medicine, please contact us at firstname.lastname@example.org or speak to your vet. Further information about veterinary medicines can be obtained from the Veterinary Medicines Directorate.
As this is a veterinary medicine our Vet Team may on occasion contact you to ensure that this product is suitable for your pet.
Due to regulatory law and safety reasons this product cannot be returned after delivery and is excluded from our returns policy and exempt from the cool-off period.
No more than a one year's supply may be purchased in any single transaction due to veterinary medicines regulatory guidelines.
Each 0.70 ml pipette contains:
Emodepside 15 mg
Praziquantel 60 mg
Butylhydroxyanisole (E320; as antioxidant) 3.78 mg
For external use only.
The cat should be accurately weighed prior to treatment to ensure that the correct pipette size is used.
Remove one pipette from package. Hold pipette in upright position, twist and pull off cap and use the opposite end of the cap to break the seal.
Part the fur on the cat's neck at the base of the skull until the skin is visible. Place the tip of the pipette on the skin and squeeze firmly several times to empty the contents directly onto the skin. Application on the base of the skull will minimise the ability of the cat to lick the product off.
The recommended minimum doses are 3 mg emodepside / kg body weight and 12 mg praziquantel / kg body weight, equivalent to 0.14 ml Dronspot / kg body weight. For the treatment of roundworms and tapeworms a single administration per treatment is effective.
|Body Weight of Cat
||Pipette size to be used
||Emodepside (mg/kg bw)
||Praziquantel (mg/kg bw)
|>2.5 - 5
||Dronspot for Medium Cats
||0.70 (1 pipette
||3 - 6
||12 - 24
Cats weighing less than 2.5 kg / over 5 kg bodyweight: use the appropriate Dronspot spot-on solution for cats.
For the treatment of queens to prevent transmission of Toxocara cati (L3 larvae) through the milk to the offspring, a single administration per treatment approximately seven days prior to expected birthing is effective.
Do not use in kittens under 8 weeks of age or weighing less than 0.5 kg.
Do not use in known cases of hypersensitivity to the active substances or to any of the excipients.
Shampooing or immersion of the animal in water directly after treatment may reduce the efficacy of the product. Treated animals therefore should not be bathed until the solution has dried.
Apply only to the skin surface and on intact skin. Do not administer orally or parenterally.
Avoid the treated cat or other cats in the household licking the site of application while it is wet.
There is limited experience on the use of the product in sick and debilitated animals. Therefore the product should not be administered to these animals.
Read the package leaflet before use.
Do not smoke, eat or drink during application.
Avoid direct contact with application area while it is wet. Keep children away from treated animals during that time.
Wash hands after use.
For animal treatment only. Keep away from children.
In case of accidental spillage onto skin, wash off immediately with soap and water.
If the product accidentally gets into eyes, they should be thoroughly flushed with plenty of water.
If skin or eye symptoms persist, or in case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
Care should be taken not to allow children to have prolonged intensive contact (for example, by sleeping) with treated cats during the first 24 hours after application of the product.
The solvent in this product may stain certain materials including leather, fabrics, plastics and finished surfaces. Allow the application site to dry before permitting contact with such materials.
Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable disease to the OIE, specific guidelines on the treatment and follow-up, and on the safeguard of persons, need to be obtained from the relevant competent authority.
Shelf life of the veterinary medicinal product as packaged for sale: 3 years
Special precautions for storage
Store in the original package in order to protect from moisture.
Store below 25°C
The veterinary medicinal product should not be allowed to enter water courses as emodepside has shown harmful effects on aquatic organisms.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.